JP MORGAN/PUT/ABBOTT LABORATORIES/90/0.1/20.09.24 Share Price

Warrant

DE000JB7UWR8

Market Closed - Börse Stuttgart 07:53:08 04/07/2024 BST
0.063 EUR +16.67% Intraday chart for JP MORGAN/PUT/ABBOTT LABORATORIES/90/0.1/20.09.24
Current month+31.71%
1 month-27.03%
Date Price Change
04/07/24 0.063 +16.67%
03/07/24 0.054 +1.89%
02/07/24 0.053 +23.26%
01/07/24 0.043 +4.88%
28/06/24 0.041 +5.13%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 07:53 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JB7UWR
ISINDE000JB7UWR8
Date issued 12/12/2023
Strike 90 $
Maturity 20/09/2024 (78 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.034
Delta-0.13x
Omega 15.08
Premium12.91x
Gearing116.85x
Moneyness 0.8795
Difference Strike -12.33 $
Difference Strike %-13.70%
Spread 0.038
Spread %38.00%
Theoretical value 0.0810
Implied Volatility 27.14 %
Total Loss Probability 84.33 %
Intrinsic value 0.000000
Present value 0.0810
Break even 89.12 €
Theta-0.01x
Vega0.01x
Rho-0x

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.3 USD
Average target price
124.9 USD
Spread / Average Target
+22.08%
Consensus